Insulin aspart, recombinant Subcutaneous and Nuplazid (Pimavanserin Tablets)
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Nuplazid (Pimavanserin Tablets) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: pimavanserin
Brand name: Nuplazid
Synonyms: Nuplazid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Nuprin
- Insulin aspart, recombinant Subcutaneous-Nuprin Backache
- Insulin aspart, recombinant Subcutaneous-Nuromax
- Insulin aspart, recombinant Subcutaneous-Nutr-E-Sol
- Insulin aspart, recombinant Subcutaneous-Nutr-E-Sol (Vitamin E Capsules and Tablets)
- Insulin aspart, recombinant Subcutaneous-Nutr-E-Sol (Vitamin E Oral Liquid)
- Nuplazid (Pimavanserin Tablets)-Insulin degludec
- Nuplazid (Pimavanserin Tablets)-Insulin Degludec (U-100) Prefilled Pens
- Nuplazid (Pimavanserin Tablets)-Insulin Degludec (U-100) Vials
- Nuplazid (Pimavanserin Tablets)-Insulin Degludec (U-200) Prefilled Pens
- Nuplazid (Pimavanserin Tablets)-Insulin degludec and liraglutide
- Nuplazid (Pimavanserin Tablets)-Insulin degludec and liraglutide Subcutaneous